Cyclerion Therapeutics, Inc.
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant…
Biotechnology
US, Cambridge [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Cyclerion Therapeutics, Inc. (CYCN) to it's peer group.
Peer Group
MNPR KRON SGTX MGTA LIPO AXLA ZIVO XFOR AMTI LRMR KZR CFRX FENC CDIO ERAS FBRX ZVSA SNTI SONN THRX
Compare Together
Loading...